论文部分内容阅读
目的:研究地佐辛复合罗哌卡因用于分娩镇痛的效果。方法:观察组(60例)接受1%罗哌卡因+0.05mg/ml地佐辛硬膜外分娩镇痛,对照组(60例)未行分娩镇痛。记录观察组VAS(视觉模拟)评分、产程时间、产后出血量、Apgar评分及不良反应。结果:观察组产妇镇痛后VAS评分低于镇痛前,第一产程明显缩短,与对照组相比有统计学意义(P<0.05)。两组产妇产后出血量及Apgar评分比较差异均无统计学意义(P>0.05)。结论:地佐辛复合罗哌卡因硬膜外分娩镇痛安全、效果好,产妇和新生儿不良反应少。
Objective: To study the effect of dezocine compound ropivacaine on labor analgesia. Methods: The observation group (60 cases) received epidural analgesia with 1% ropivacaine + 0.05 mg / ml dexrazoxane, while the control group (60 cases) did not have labor analgesia. The VAS (visual analogue) score, labor duration, postpartum hemorrhage, Apgar score and adverse reactions in the observation group were recorded. Results: The VAS score in the observation group was lower than that before the analgesia, and the first stage of labor was significantly shorter in the observation group than in the control group (P <0.05). There was no significant difference in postpartum hemorrhage volume and Apgar score between the two groups (P> 0.05). Conclusion: The dezocine compound ropivacaine is safe and effective in epidural analgesia and has few adverse reactions in maternal and newborn.